How were Isoray's earnings last quarter?

Isoray, Inc. (NYSE:ISR) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The company had revenue of $2.56 million for the quarter, compared to analyst estimates of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 17.12% and a negative net margin of 115.91%.

NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free ISR Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.28
▼
$0.42
52-Week Range: N/A

Volume: 145,000 shs
Average Volume: 290,697 shs
Market Capitalization: $54.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Isoray alerts:

Ad DTI

A new way to collect income from stocks

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

About Isoray Stock (NYSE:ISR)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Ad DTI

A new way to collect income from stocks

Click here to see me place one of these trades LIVE on camera.

ISR Stock News Headlines

November 22, 2023 | morningstar.com

French ISR Label Revamp Report

April 24, 2023 | thestreet.com

Why IsoRay (ISR) Is Plunging Today

April 17, 2024 | DTI (Ad)

A new way to collect income from stocks

March 16, 2023 | thestreet.com

Why IsoRay (ISR) Stock Is Surging Today

February 16, 2023 | finance.yahoo.com

IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates

February 16, 2023 | finance.yahoo.com

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022

February 8, 2023 | finanznachrichten.de

Isoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

February 7, 2023 | finance.yahoo.com

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

April 17, 2024 | DTI (Ad)

A new way to collect income from stocks

February 6, 2023 | finance.yahoo.com

Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine

January 30, 2023 | benzinga.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 30, 2023 | finance.yahoo.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 14, 2023 | thestreet.com

Why IsoRay (ISR) Hit a Five-Year High Today (Update)

January 12, 2023 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023

December 14, 2022 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022

December 14, 2022 | finance.yahoo.com

AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

December 6, 2022 | proactiveinvestors.com

Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023

December 6, 2022 | proactiveinvestors.com

Isoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular Targeting

November 25, 2022 | finance.yahoo.com

Isoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo Finance

November 11, 2022 | finanznachrichten.de

Isoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

November 10, 2022 | seekingalpha.com

Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript

November 10, 2022 | finance.yahoo.com

Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

October 31, 2022 | finance.yahoo.com

Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022

October 20, 2022 | seekingalpha.com

Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha

October 18, 2022 | businesswire.com

Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Business Wire

October 18, 2022 | finance.yahoo.com

Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT

October 16, 2022 | benzinga.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, BTRS, ISR, JVA - Isoray (AMEX:ISR), BTRS H - Benzinga

See More Headlines

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/17/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NYSE:ISR
CUSIP: N/A
CIK: 728387
Web: isoray.com
Phone: (509) 375-1202
Fax: 509-267-3670
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,270,000.00
Net Margins: -115.91%
Pretax Margin: -91.45%
Return on Equity: -17.12%
Return on Assets: -16.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 14.38
Quick Ratio: 13.99

Sales & Book Value

Annual Sales: $10.80 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.43 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 142,110,000
Free Float: 138,674,000
Market Cap: $54.57 million
Optionable: Not Optionable
Beta: 1.48

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Lori A. Woods
Chief Executive Officer & Director
Jennifer Streeter
Chief Operating Officer & VP-Human Resources
Mark J. Austin
Co-CFO, Secretary & Chief Accounting Officer
Jonathan R. Hunt
CFO & Principal Financial Officer
William A. Cavanagh
Chief Research & Development Officer

Key Competitors

View All Competitors

ISR Stock Analysis - Frequently Asked Questions

How were Isoray's earnings last quarter?: Isoray, Inc. (NYSE:ISR) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The company had revenue of $2.56 million for the quarter, compared to analyst estimates of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 17.12% and a negative net margin of 115.91%.

This page (NYSE:ISR) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Isoray (ISR) Stock Price, News & Analysis

About Isoray Stock (NYSE:ISR)

ISR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ISR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info